Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy-Reference-Cited by-同舟云学术

Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Published:2016-06-02 Issue:22 Volume:127 Page:2742-2750
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Wang Wei¹,Cortes Jorge E.²,Tang Guilin¹,Khoury Joseph D.¹,Wang Sa¹,Bueso-Ramos Carlos E.¹,DiGiuseppe Joseph A.³,Chen Zi¹,Kantarjian Hagop M.²,Medeiros L. Jeffrey¹,Hu Shimin¹

Affiliation:

1. Department of Hematopathology and

2. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and

3. Department of Pathology, Hartford Hospital, Hartford, CT

Abstract

Key Points Based on their impact on treatment and survival, ACAs in CML were stratified into good and poor prognostic groups. ACAs in the good prognostic group showed no adverse impact on survival when they emerged from chronic phase or at the initial CML diagnosis.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/127/22/2742/1393211/2742.pdf

Reference31 articles.

1. Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression.;Marktel;Haematologica,2003

2. Revised international prognostic scoring system for myelodysplastic syndromes.;Greenberg;Blood,2012

3. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.;Grimwade;Blood,2010

4. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.;Baccarani;Blood,2013

5. Chronic myeloid leukemia.;Fioretos,2009

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT);Transplantation and Cellular Therapy;2024-01

2. Patterns of chromosome abnormalities in a sample of Colombian patients with chronic myeloid leukemia;Universitas Scientiarum;2023-12-21

3. Accelerated-phase CML: de novo and transformed;Hematology;2023-12-08

4. The study of the impact of additional chromosomal aberrations and c-MYC and BCR::ABL1 genes amplification on CML patient’s characteristics: relation to haematological parameters and patient outcome;Egyptian Journal of Medical Human Genetics;2023-12-06

5. European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia;Leukemia;2023-10-04